Virtual West Oncology Conference
Playback speed
10 seconds
2021 Advanced NSCLC Targeted Therapy Updates: Efficacy & Safety Profile of Larotrectinib & Entrectinib for NTRK Fusion, Dabrafenib+Trametinib Combo in BRAF Mutated Disease
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
By
Virtual West Oncology Conference
FEATURING
Erminia Massarelli
151 views
March 4, 2021
Login to view comments.
Click here to Login
Videos